3-乙氧基-N,N-二甲基丙胺 | 25277-18-3

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 3-乙氧基-N,N-二甲基丙胺
• 英文名称: N,N-dimethyl-3-ethoxypropylamine
• 英文别名: (3-ethoxy-propyl)-dimethyl-amine；Aethyl-(γ-dimethylamino-propyl)-aether；(3-Aethoxy-propyl)-dimethyl-amin；Dimethyl-(γ-aethoxy-propyl)-amin；3-ethoxy-N,N-dimethylpropylamine；3-ethoxy-N,N-dimethylpropan-1-amine
• CAS: 25277-18-3
• 化学式: C₇H₁₇NO
• 分子量: 131.218
• InChiKey: XLAXYNXVOVMHMJ-UHFFFAOYSA-N

物化性质

• 沸点：
  145.9±23.0 °C(Predicted)
• 密度：
  0.832±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  9
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2922199090

反应信息

• 作为产物：
  描述：

  sodium ethanolate 、 N,N-二甲基-3-氯丙胺 生成 3-乙氧基-N,N-二甲基丙胺
  参考文献：
  名称：

  Knorr; Roth, Chemische Berichte, 1906, vol. 39, p. 1425

  摘要：

  DOI：

文献信息

• SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS
  申请人：Syngenta Crop Protection AG

  公开号：US20200315174A1

  公开（公告）日：2020-10-08

  The invention relates to substituted thiophenyl uracils of general formula (I) or the salts (I) thereof, wherein the groups in general formula (I) are as defined in the description, and to the use thereof as herbicides, in particular for controlling weeds and/or weed grasses in crops of cultivated plants and/or as plant growth regulators for influencing the growth of crops of cultivated plants.

  本发明涉及取代噻吩基尿嘧啶的通式(I)或其盐(I)，其中通式(I)中的基团如描述中定义，以及作为除草剂，特别是用于控制作物中的杂草和/或杂草草本的用途，以及作为植物生长调节剂用于影响栽培植物作物的生长。
• Process of telomerizing conjugated dienes
  申请人：Celanese Chemicals Europe GmbH

  公开号：EP1201634A1

  公开（公告）日：2002-05-02

  The present invention is related to a process for telomerizing a conjugated diene which comprises reacting said conjugated diene with a compound containing active hydrogen in the presence of a catalyst system comprising at least one transition metal compound, at least one phosphorus-containing compound, and at least one salt which forms a liquid under the conditions of the telomerization process.

  本发明涉及一种用于对共轭二烯进行缩聚的方法，包括在存在至少一种过渡金属化合物、至少一种含磷化合物和至少一种在缩聚过程条件下形成液体的盐的催化剂体系的情况下，将所述共轭二烯与含活性氢的化合物反应的过程。
• [EN] MTORC MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE MTORC ET LEURS UTILISATIONS
  申请人：AEOVIAN PHARMACEUTICALS INC

  公开号：WO2020154447A1

  公开（公告）日：2020-07-30

  Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.

  本文披露了新型雷帕霉素类似物及其用途。本公开的雷帕霉素类似物相对于雷帕霉素表现出增加的mTORC1特异性和降低的mTORC2特异性。
• DERIVATIVES OF PYRAZOLE 3,5-CARBOXYLATES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
  申请人：FORICHER Yann

  公开号：US20100160377A1

  公开（公告）日：2010-06-24

  The invention relates to derivatives of pyrazole 3,5-carboxylates, of general formula (I): in which R 1 , R 2 , R 3 , R 4 , R 5 , X, Y, V, W and n are as defined herein. The invention also relates to salts of these compounds as well as hydrates or of solvates, enantiomers, diastereoisomers and mixtures thereof. Also disclosed are the methods of preparation and application in therapeutics of compounds of formula (I).

  这项发明涉及吡唑3,5-羧酸酯的衍生物，其一般式为(I)：其中R1、R2、R3、R4、R5、X、Y、V、W和n如本文所定义。该发明还涉及这些化合物的盐以及其水合物或溶剂合物、对映体、二对映异构体和它们的混合物。还公开了制备方法以及在治疗学中应用式(I)化合物的方法。
• FACTOR XA INHIBITORS
  申请人：Zhu Bing-Yan

  公开号：US20090298806A1

  公开（公告）日：2009-12-03

  The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.

  本发明涉及由公式I表示的化合物及其药学上可接受的盐、溶剂化合物、水合物和前药，这些化合物是凝血因子Xa的抑制剂。本发明还涉及制备这些化合物所使用的中间体，含有这些化合物的药物组合物，预防或治疗一系列由不良血栓形成表征的疾病的方法，以及抑制血样的凝血的方法。